Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rodger

Showing results (251-260 of 295) with videos related to

Pageof 30
Sort By:
BMJ (Clinical Research Ed.)|March 19, 2017
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyMarc A Rodger, Gregoire Le Gal, David R Anderson, et al.
British Journal of Haematology|April 27, 2011
Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolismMarc A Rodger, Natasha Kekre, Grégoire Le Gal, et al.
The European Respiratory Journal|May 18, 2019
The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screeningKathryn Gracie, Martyn P T Kennedy, Georgina Esterbrook, et al.
The American Journal of Medicine|April 13, 2017
Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort StudySusan R Kahn, Arash Akaberi, John T Granton, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2021
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort studyDavid Aziz, Leslie Skeith, Marc A Rodger, et al.
Annals of the Rheumatic Diseases|July 24, 2008
Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritisJ E Hollis-Moffatt, M E Merriman, R A Rodger, et al.
Thrombosis Research|June 29, 2010
Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTEM A Rodger, G Le Gal, Marc Carrier, et al.
Thrombosis and Haemostasis|September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort studyEsteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemicDivya Karsanji, James A King, Jenny Godley, et al.
Chest|December 10, 2016
Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort StudySusan R Kahn, Andrew M Hirsch, Arash Akaberi, et al.
Pageof 30

Showing results (251-260 of 295) with videos related to

Sort By:
Pageof 30
BMJ (Clinical Research Ed.)|March 19, 2017
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyMarc A Rodger, Gregoire Le Gal, David R Anderson, et al.
British Journal of Haematology|April 27, 2011
Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolismMarc A Rodger, Natasha Kekre, Grégoire Le Gal, et al.
The European Respiratory Journal|May 18, 2019
The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screeningKathryn Gracie, Martyn P T Kennedy, Georgina Esterbrook, et al.
The American Journal of Medicine|April 13, 2017
Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort StudySusan R Kahn, Arash Akaberi, John T Granton, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2021
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort studyDavid Aziz, Leslie Skeith, Marc A Rodger, et al.
Annals of the Rheumatic Diseases|July 24, 2008
Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritisJ E Hollis-Moffatt, M E Merriman, R A Rodger, et al.
Thrombosis Research|June 29, 2010
Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTEM A Rodger, G Le Gal, Marc Carrier, et al.
Thrombosis and Haemostasis|September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort studyEsteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemicDivya Karsanji, James A King, Jenny Godley, et al.
Chest|December 10, 2016
Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort StudySusan R Kahn, Andrew M Hirsch, Arash Akaberi, et al.
Pageof 30